Keyphrases
Randomized Placebo-controlled Trial
100%
Nicotinamide
100%
Hemodialysis Patients
100%
Phosphorus Reduction
100%
Serum Phosphorus
44%
Placebo
33%
Adverse Effects
11%
Randomized Trial
11%
Randomized Double-blind
11%
Placebo-controlled
11%
Triglycerides
11%
Sodium
11%
Prospective Randomized Trial
11%
Chronic Kidney Disease
11%
Serum Calcium
11%
Platelets
11%
LDL Cholesterol
11%
Intact Parathyroid Hormone (iPTH)
11%
Alternative Therapy
11%
Washout Period
11%
Uric Acid
11%
Phosphorus Levels
11%
Vitamin D Analogs
11%
Binder
11%
Calcimimetics
11%
Total Cholesterol Level
11%
Phosphate Transporter
11%
Calcium-phosphorus Product
11%
Safety Criteria
11%
Serum HDL
11%
LDL Cholesterol Level
11%
Phosphorus Binder
11%
Medicine and Dentistry
Placebo
100%
Hemodialysis
100%
Nicotinamide
100%
Isotopes of Calcium
22%
Adverse Event
11%
Arm
11%
Platelet
11%
High Density Lipoprotein Cholesterol
11%
Triacylglycerol
11%
Chronic Kidney Disease
11%
Parathyroid Hormone
11%
Vitamin D Analog
11%
Uric Acid
11%
Calcimimetic
11%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Hemodialysis
100%
Nicotinamide
100%
Adverse Event
11%
Triacylglycerol
11%
Chronic Kidney Failure
11%
Parathyroid Hormone
11%
High Density Lipoprotein Cholesterol
11%
Vitamin D Analog
11%
Uric Acid
11%
Biochemistry, Genetics and Molecular Biology
Hemodialysis
100%
Nicotinamide
100%
Phosphate Blood Level
44%
Triglyceride
11%
HDL-Cholesterol
11%
Calcium Blood Level
11%
Parathyroid Hormone
11%
Vitamin D Analog
11%
Low Density Lipoprotein Cholesterol Level
11%
Total Cholesterol Level
11%
Platelet
11%
Agricultural and Biological Sciences
Placebo
100%
Triglyceride
20%
High Density Lipoprotein Cholesterol
20%
Parathyroid Hormone
20%
Vitamin D
20%
Adverse Effects
20%
Uric Acid
20%